KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Net Income - Minority (2016 - 2024)

Bristol Myers Squibb has reported Net Income - Minority over the past 15 years, most recently at -$58.0 million for Q3 2024.

  • Quarterly Net Income - Minority changed N/A to -$58.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$58.0 million through Sep 2024, changed N/A year-over-year, with the annual reading at -$55.0 million for FY2023, N/A changed from the prior year.
  • Net Income - Minority was -$58.0 million for Q3 2024 at Bristol Myers Squibb, down from -$54.0 million in the prior quarter.
  • Over five years, Net Income - Minority peaked at -$54.0 million in Q2 2024 and troughed at -$72.0 million in Q3 2020.
  • The 4-year median for Net Income - Minority is -$66.0 million (2020), against an average of -$63.6 million.
  • Year-over-year, Net Income - Minority soared 40.0% in 2020 and then fell 3.03% in 2021.
  • A 4-year view of Net Income - Minority shows it stood at -$60.0 million in 2020, then decreased by 18.33% to -$71.0 million in 2021, then increased by 22.54% to -$55.0 million in 2023, then decreased by 5.45% to -$58.0 million in 2024.
  • Per Business Quant, the three most recent readings for BMY's Net Income - Minority are -$58.0 million (Q3 2024), -$54.0 million (Q2 2024), and -$55.0 million (Q4 2023).